EN | UA
EN | UA

Help Support

Back

Study enlightens sedation needs for hospitalized COVID-19 patients

Study enlightens sedation needs for hospitalized COVID-19 patients Study enlightens sedation needs for hospitalized COVID-19 patients
Study enlightens sedation needs for hospitalized COVID-19 patients Study enlightens sedation needs for hospitalized COVID-19 patients

What's new?

More sedative and analgesic infusions are required for managing critically ill COVID-19 patients.

The results of a recent retrospective, single-center cohort study published in the American Journal of Health-System Pharmacy confirmed the increased sedative usage in critically-ill COVID-19 patients corresponding to sedation practices as per guidelines in other critically ill patients.

Aditi Balakrishna et al. performed this study to assess the use of sedatives in 86 critically ill, mechanically ventilated COVID-19 patients.

The routine use of sedative medicines, doses, drug combinations, and duration of administration were noted and compared to published guidelines for sedation of critically ill patients. Associations between doses, number of drugs used, baseline patient characteristics, and inflammatory markers were examined.

Initially, the combination of propofol and hydromorphone was frequently used, with these drugs being used on a given day in about 100% and 88% of patients, respectively. In the first 10 days, the doses of sedative and analgesic infusions increased, as per published dosage recommendations for propofol (48% of patients), hydromorphone (38%), ketamine (32%), dexmedetomidine (29%), and midazolam (7.7%).

By day 2, the simultaneous administration of sedative and analgesic agents augmented over time for each patient, with >50% of patients needing 3 or more drugs. This group comprised of younger patients with increased body mass index, serum ferritin, and lactate dehydrogenase concentrations, and a lower PaO2:FIO2 (ratio of arterial partial pressure of oxygen to fraction of inspired oxygen) and those who were expected to receive a neuromuscular block.

Thus, there is a raised sedative use in critically ill coronavirus-infected patients requiring mechanical ventilation.

Source:

American Journal of Health-System Pharmacy : AJHP

Article:

An examination of sedation requirements and practices for mechanically ventilated critically ill patients with COVID-19

Authors:

Aditi Balakrishna et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: